These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis? Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043 [TBL] [Abstract][Full Text] [Related]
10. Multilocus genetic risk scores for venous thromboembolism risk assessment. Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889 [TBL] [Abstract][Full Text] [Related]
11. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients? Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797 [TBL] [Abstract][Full Text] [Related]
12. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M; Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523 [TBL] [Abstract][Full Text] [Related]
13. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in neonates and children. Kenet G; Nowak-Göttl U Best Pract Res Clin Haematol; 2012 Sep; 25(3):333-44. PubMed ID: 22959549 [TBL] [Abstract][Full Text] [Related]
15. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation. Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457 [TBL] [Abstract][Full Text] [Related]
16. The genetics of venous thromboembolism: a systematic review of thrombophilia families. Zhang Y; Zhang Z; Shu S; Niu W; Xie W; Wan J; Zhai Z; Wang C J Thromb Thrombolysis; 2021 Feb; 51(2):359-369. PubMed ID: 32623564 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic Risk Determined by Protein C Receptor (PROCR) Variants among Middle-Aged and Older Adults: A Population-Based Cohort Study. Manderstedt E; Halldén C; Lind-Halldén C; Elf J; Svensson PJ; Engström G; Melander O; Baras A; Lotta LA; Zöller B; Thromb Haemost; 2022 Aug; 122(8):1326-1332. PubMed ID: 35021256 [TBL] [Abstract][Full Text] [Related]
18. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation. Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364 [TBL] [Abstract][Full Text] [Related]
19. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes. Segers O; Simioni P; Tormene D; Castoldi E Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152 [TBL] [Abstract][Full Text] [Related]